Biotech SF: Oraya Therapeutics

Showing posts with label Oraya Therapeutics. Show all posts

Wednesday, May 18, 2011

Oraya promises another wet AMD study after eye device trial fills

Oraya Therapeutics Inc. completed enrollment in a trial of its experimental device to treat a common cause of blindness and plans another large trial later this year.
The Newark company said the 226-patient study of its iRay device is designed to study both the effectiveness and safety of its radiation therapy of wet age-related macular degeneration, or wet AMD, in conjunction with standard-of-care drug injections into the eye.

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.